# Trade Mark Journal No.2026/016 17 April 2026

## WO0000001907104 (5)

Office of origin: United States of America

Date of International Registration:6 February 2026
Date of designation in the UK: 12 March 2026

Class 5
  Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of immune system related diseases and disorders.

Viridian Therapeutics, Inc.

Representative: Valerie Brennan Plave Koch PLC, 3120 Fairview Park Drive, Suite 420, Falls Church VA 22042, UNITED STATES OF AMERICA